Latest filing published 13 May 2025 for Lexicon Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christopher J. Sobecki, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in WW International, Inc. and Lexicon Pharmaceuticals, Inc. Over a trading history stretching from 4 January 2016 to 13 May 2025, the count stands at 14 filings.
No open-market sale appears; the market trades are 1 purchase worth €120k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 share grants and 4 option exercises.
Most recently, on 13 May 2025, the filings show an option exercise in Lexicon Pharmaceuticals, Inc. The clock since the last published purchase (21 November 2022) now reads 1,427 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations